A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• age greater than 18 years
• scheduled for an elective laparoscopic gastric bypass procedure
Locations
United States
California
UC Davis Medical Center
RECRUITING
Sacramento
Contact Information
Primary
Ana P Arias, BS
apaarias@ucdavis.edu
916-703-5456
Backup
Julio J Arana Pineda, BA
jjaranapineda@ucdavis.edu
916-734-4074
Time Frame
Start Date: 2023-02-08
Estimated Completion Date: 2025-07
Participants
Target number of participants: 215
Related Therapeutic Areas
Sponsors
Leads: University of California, Davis